亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)卡馬西平

 
 
單價(jià) 350.00 / kg對(duì)比
銷(xiāo)量 暫無(wú)
發(fā)貨 湖北鄂州市預(yù)售,付款后7天內(nèi)
庫(kù)存 10000kg起訂25kg
品牌 恒通
型號(hào) 298-46-4
規(guī)格 CP2010
過(guò)期 長(zhǎng)期有效
更新 2014-03-26 10:10
 

鄂州市恒通偉業(yè)化工有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

中文名稱: 卡馬西平 

中文別名: 5H-二苯并[b,f]氮雜卓-5-甲酰胺  

英文名稱: Carbamazepine-d10 

CAS號(hào): 298-46-4 

EINECS號(hào): 206-062-7 

分子式: C15H12N2O 

分子量: 236.2686  

分子結(jié)構(gòu): 
     卡馬西平 298-46-4  

密度: 1.266g/cm3  

熔點(diǎn): 189-192℃  

沸點(diǎn): 411°C at 760 mmHg  

閃點(diǎn): 202.4°C  

水溶性: pract. insoluble  

蒸汽壓: 5.78E-07mmHg at 25°C  

產(chǎn)品用途: 

抗驚厥藥,用于治療癲癇大發(fā)作和精神運(yùn)動(dòng)性癲癇,還可治療三叉神經(jīng)痛 

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)頭孢克肟側(cè)鏈酸活性酯 供應(yīng)還原型谷胱甘肽 供應(yīng)鹽酸金霉素 供應(yīng)氯霉素 供應(yīng)鹽霉素 供應(yīng)乙硫異煙胺 供應(yīng)羥基脲 供應(yīng)硫酸長(zhǎng)春新堿
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |